Remdesivir price slashed by 25-70%
Our Bureaus
New Delhi/Hyderabad/Bengaluru |
Updated on
April 17, 2021
× As reports of shortages and black-marketing of antiviral Remdesivir come in from across the country, the Centre intervened to make the injectable more affordable for patients.
Seven companies licensed to make the drug in India have “voluntarily lowered” their prices per 100mg/vial, in the range of 25-70 per cent. The companies include Cadila Healthcare, Syngene International, Dr Reddy’s Laboratories, Cipla, Mylan, Jubilant Generics and Hetero Healthcare, a note from the National Pharmaceutical Pricing Authority said.
States crack down
This, even as Andhra Pradesh cracked the whip and capped Remdesivir price at ₹2,500 for 100mg; Karnataka threatened action against black-marketeers, and Maharashtra started a toll-free number for patients needing the drug.
Indian coronavirus tally reaches 2 34 lakhs | Coronavirus India News
andhrawishesh.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from andhrawishesh.com Daily Mail and Mail on Sunday newspapers.
Modi appeals for low-key Hindu festival as India s COVID-19 infections surge
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Modi appeals for low-key Hindu festival as India s COVID-19 infections surge
bdnews24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bdnews24.com Daily Mail and Mail on Sunday newspapers.